Novel Point-of-Care Device Simultaneously Detects Bacterial Growth and Tests Antibiotic Susceptibility
|
By LabMedica International staff writers Posted on 02 Mar 2020 |

Image: Schematic of the laser fabricated three-layer paper device for bacteria (Photo courtesy of University of Southampton)
A novel paper-based point-of-care device that combines detection of pathogenic bacteria with determination of antibiotic susceptibility is expected to reduce the number of unnecessary antibiotic prescriptions and aid in the on-going struggle to prevent development of antibiotic resistance.
Antimicrobial resistance (AMR) has been identified by the World Health Organization as a global threat that currently claims at least 25,000 deaths each year in Europe and 700,000 world-wide. The number of fatalities attributed to AMR is projected to reach 10 million per year between 2015 and 2050. Therefore, there is an urgent need for low-cost but reliable point-of-care diagnostics for early screening of infections especially in developing countries lacking in health care infrastructure and trained personnel.
To this end, investigators at the University of Southampton (United Kingdom) developed a laser-patterned paper-based device for detection and susceptibility testing of Escherichia coli, the main cause of urinary tract infections, via a simple visually observable color change.
The test device comprises three layers - a top paper layer containing four common antibiotics in confined rectangular areas, an absorbent paper in the middle, and an agar gel-containing base layer, all sealed in a plastic casing.
A test is performed by adding a liquid sample (such as urine) to a small paper tab, which is then covered with tape to prevent drying out or contamination. The sample diffuses across the middle paper layer and through the four rectangles containing the test antibiotics (amoxicillin, ciprofloxacin, gentamicin and nitrofurantoin). If bacteria are present in the sample, their growth will cause the paper to turn blue. If the bacteria are susceptible to one (or more) of the antibiotics, a clear patch caused by growth inhibition will be seen around the corresponding rectangle.
In comparison studies using artificial urine spiked with E.coli, the new paper-based device gave results similar to those obtained by growth in petri dishes with agar gel.
"By enabling doctors to quickly determine if an infection is caused by bacteria, and if the bacteria are resistant to four common antibiotics, this device could cut down on unnecessary antibiotic prescriptions and help fight the growing threat of antibiotic resistance," said senior author Dr. Collin Sones, associate professor of optoelectronics research at the University of Southampton.
The device for simultaneous detection and antibiotic-resistance testing of bacterial infections was described in the March 15, 2020, online edition of the journal Biosensors and Bioelectronics.
Related Links:
University of Southampton
Antimicrobial resistance (AMR) has been identified by the World Health Organization as a global threat that currently claims at least 25,000 deaths each year in Europe and 700,000 world-wide. The number of fatalities attributed to AMR is projected to reach 10 million per year between 2015 and 2050. Therefore, there is an urgent need for low-cost but reliable point-of-care diagnostics for early screening of infections especially in developing countries lacking in health care infrastructure and trained personnel.
To this end, investigators at the University of Southampton (United Kingdom) developed a laser-patterned paper-based device for detection and susceptibility testing of Escherichia coli, the main cause of urinary tract infections, via a simple visually observable color change.
The test device comprises three layers - a top paper layer containing four common antibiotics in confined rectangular areas, an absorbent paper in the middle, and an agar gel-containing base layer, all sealed in a plastic casing.
A test is performed by adding a liquid sample (such as urine) to a small paper tab, which is then covered with tape to prevent drying out or contamination. The sample diffuses across the middle paper layer and through the four rectangles containing the test antibiotics (amoxicillin, ciprofloxacin, gentamicin and nitrofurantoin). If bacteria are present in the sample, their growth will cause the paper to turn blue. If the bacteria are susceptible to one (or more) of the antibiotics, a clear patch caused by growth inhibition will be seen around the corresponding rectangle.
In comparison studies using artificial urine spiked with E.coli, the new paper-based device gave results similar to those obtained by growth in petri dishes with agar gel.
"By enabling doctors to quickly determine if an infection is caused by bacteria, and if the bacteria are resistant to four common antibiotics, this device could cut down on unnecessary antibiotic prescriptions and help fight the growing threat of antibiotic resistance," said senior author Dr. Collin Sones, associate professor of optoelectronics research at the University of Southampton.
The device for simultaneous detection and antibiotic-resistance testing of bacterial infections was described in the March 15, 2020, online edition of the journal Biosensors and Bioelectronics.
Related Links:
University of Southampton
Latest Technology News
- Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
- AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
- AI-Powered Biosensor Technology to Enable Breath Test for Lung Cancer Detection
- AI Model Achieves Breakthrough Accuracy in Ovarian Cancer Detection
- Portable Biosensor Diagnoses Psychiatric Disorders Using Saliva Samples
- Cell-Sorting Device Uses Electromagnetic Levitation to Precisely Direct Cell Movement

- Embedded GPU Platform Enables Rapid Blood Profiling for POC Diagnostics
- Viral Biosensor Test Simultaneously Detects Hepatitis and HIV
- Acoustofluidic Device to Transform Point-Of-Care sEV-Based Diagnostics
- AI Algorithm Assesses Progressive Decline in Kidney Function
Channels
Clinical Chemistry
view channel
Chemical Imaging Probe Could Track and Treat Prostate Cancer
Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read more
Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read moreMolecular Diagnostics
view channel
Simple Urine Test to Revolutionize Bladder Cancer Diagnosis and Treatment
Bladder cancer is one of the most common and deadly urological cancers and is marked by a high rate of recurrence. Diagnosis and follow-up still rely heavily on invasive cystoscopy or urine cytology, which... Read more
Blood Test to Enable Earlier and Simpler Detection of Liver Fibrosis
Persistent liver damage caused by alcohol misuse or viral infections can trigger liver fibrosis, a condition in which healthy tissue is gradually replaced by collagen fibers. Even after successful treatment... Read moreHematology
view channel
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
Since HIV was identified in 1983, more than 91 million people have contracted the virus, and over 44 million have died from related causes. Today, nearly 40 million individuals worldwide live with HIV-1,... Read more
Gene Signature Test Predicts Response to Key Breast Cancer Treatment
DK4/6 inhibitors paired with hormone therapy have become a cornerstone treatment for advanced HR+/HER2– breast cancer, slowing tumor growth by blocking key proteins that drive cell division.... Read more
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read morePathology
view channel
Tunable Cell-Sorting Device Holds Potential for Multiple Biomedical Applications
Isolating rare cancer cells from blood is essential for diagnosing metastasis and guiding treatment decisions, but remains technically challenging. Many existing techniques struggle to balance accuracy,... Read moreAI Tool Outperforms Doctors in Spotting Blood Cell Abnormalities
Diagnosing blood disorders depends on recognizing subtle abnormalities in cell size, shape, and structure, yet this process is slow, subjective, and requires years of expert training. Even specialists... Read moreTechnology
view channel
Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Identifying which genetic variants actually cause disease remains one of the biggest challenges in genomic medicine. Each person carries tens of thousands of DNA changes, yet only a few meaningfully alter... Read more
AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
Early detection of head and neck cancer remains difficult because the disease produces few or no symptoms in its earliest stages, and lesions often lie deep within the head or neck, where biopsy or endoscopy... Read moreIndustry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more








